Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Merck Frosst's new generation of 5-LO inhibitors

April 26, 1996

Taisho's erythromycin A derivatives suppress IL-5 production

April 26, 1996

New antiasthmatic drugs patented by Fujirebio

April 26, 1996

Nikken Chemicals claims new antiasthmatic compounds

April 26, 1996

Update on terfenadine carboxylate progress

April 26, 1996

SKB discloses NK3 antagonists in patent literature

April 19, 1996

Nikken Chemicals describes antiallergy agents

April 19, 1996

CMI-568, dual PAF antagonist and 5-LO inhibitor from CytoMed

April 19, 1996

Abbott claims new 5-LO inhibitors

April 19, 1996

Two novel series of LTB4 antagonists from Boehringer Ingelheim

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.